Citadel Advisors - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J908. A total of 2 filers reported holding SAGE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$346,000
-30.9%
11,500
+33.7%
0.00%
-100.0%
Q4 2015$501,000
+46.1%
8,600
+6.2%
0.00%
Q3 2015$343,000
+124.2%
8,100
+285.7%
0.00%
Q2 2015$153,0002,1000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 76$657,0000.02%
GROUP ONE TRADING, L.P. 66,700$5,770,0000.01%
SIMPLEX TRADING, LLC 275$2,379,0000.00%
IMC-Chicago, LLC 15,200$1,315,0000.00%
JPMORGAN CHASE & CO 44,200$3,824,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAGE THERAPEUTICS INC shareholders